Actinium Pharmaceuticals Statistics
Total Valuation
ATNM has a market cap or net worth of $211.76 million. The enterprise value is $129.69 million.
| Market Cap | 211.76M |
| Enterprise Value | 129.69M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ATNM has 29.78 million shares outstanding. The number of shares has increased by 8.52% in one year.
| Shares Outstanding | 29.78M |
| Shares Change (YoY) | +8.52% |
| Shares Change (QoQ) | +1.67% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 26.95% |
| Float | 29.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.84 |
| PS Ratio | 2,614.33 |
| Forward PS | n/a |
| PB Ratio | 4.83 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,601.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.59, with a Debt / Equity ratio of 0.05.
| Current Ratio | 10.59 |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -105.00% and return on invested capital (ROIC) is -108.93%.
| Return on Equity (ROE) | -105.00% |
| Return on Assets (ROA) | -51.90% |
| Return on Capital (ROIC) | -108.93% |
| Revenue Per Employee | $1,653 |
| Profits Per Employee | -$947,980 |
| Employee Count | 49 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.80% in the last 52 weeks. The beta is 0.20, so ATNM's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -1.80% |
| 50-Day Moving Average | 8.01 |
| 200-Day Moving Average | 6.66 |
| Relative Strength Index (RSI) | 42.48 |
| Average Volume (20 Days) | 244,661 |
Short Selling Information
The latest short interest is 1.88 million, so 6.32% of the outstanding shares have been sold short.
| Short Interest | 1.88M |
| Short Previous Month | 1.81M |
| Short % of Shares Out | 6.32% |
| Short % of Float | 6.49% |
| Short Ratio (days to cover) | 8.47 |
Income Statement
In the last 12 months, ATNM had revenue of $81,000 and -$46.45 million in losses. Loss per share was -$1.71.
| Revenue | 81,000 |
| Gross Profit | 81,000 |
| Operating Income | -49.93M |
| Pretax Income | -46.45M |
| Net Income | -46.45M |
| EBITDA | -45.63M |
| EBIT | -46.45M |
| Loss Per Share | -$1.71 |
Balance Sheet
The company has $84.06 million in cash and $1.98 million in debt, giving a net cash position of $82.08 million or $2.76 per share.
| Cash & Cash Equivalents | 84.06M |
| Total Debt | 1.98M |
| Net Cash | 82.08M |
| Net Cash Per Share | $2.76 |
| Equity (Book Value) | 43.86M |
| Book Value Per Share | 1.47 |
| Working Capital | 77.31M |
Cash Flow
In the last 12 months, operating cash flow was -$39.63 million and capital expenditures -$88,000, giving a free cash flow of -$39.72 million.
| Operating Cash Flow | -39.63M |
| Capital Expenditures | -88,000 |
| Free Cash Flow | -39.72M |
| FCF Per Share | -$1.42 |
Margins
Gross margin is 100.00%, with operating and profit margins of -61,645.68% and -57,346.91%.
| Gross Margin | 100.00% |
| Operating Margin | -61,645.68% |
| Pretax Margin | -57,346.91% |
| Profit Margin | -57,346.91% |
| EBITDA Margin | -56,329.63% |
| EBIT Margin | -57,346.91% |
| FCF Margin | -49,037.04% |
Dividends & Yields
ATNM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.52% |
| Shareholder Yield | -8.52% |
| Earnings Yield | -21.94% |
| FCF Yield | -18.76% |
Analyst Forecast
The average price target for ATNM is $25.60, which is 260.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.60 |
| Price Target Difference | 260.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 441.44% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 11, 2020. It was a reverse split with a ratio of 1:30.
| Last Split Date | Aug 11, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
ATNM has an Altman Z-Score of -3.32 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.32 |
| Piotroski F-Score | 2 |